Patient Pathfinder: Clinical Trials
Clinical Trials for Esophageal Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 189 active Esophageal Cancer trials
A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma
Study Type: Interventional Phase 3
Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System
Study Type: Interventional
Combination of TATE and PD-1 Inhibitor in Liver Cancer
Study Type: Interventional Phase 2
Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer
Study Type: Interventional Phase 1
Genetic and Environmental Risk Factors Related to Esophageal Cancer
Study Type: Observational
Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence
Study Type: Observational
Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer
Study Type: Interventional Phase 2
Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer
Study Type: Interventional Phase 1
There are 189 active Esophageal Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now